Mari Odashima

641 total citations
7 papers, 538 citations indexed

About

Mari Odashima is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Animal Science and Zoology. According to data from OpenAlex, Mari Odashima has authored 7 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Animal Science and Zoology. Recurrent topics in Mari Odashima's work include Signaling Pathways in Disease (4 papers), Animal Nutrition and Physiology (2 papers) and Cardiac Fibrosis and Remodeling (2 papers). Mari Odashima is often cited by papers focused on Signaling Pathways in Disease (4 papers), Animal Nutrition and Physiology (2 papers) and Cardiac Fibrosis and Remodeling (2 papers). Mari Odashima collaborates with scholars based in Japan and United States. Mari Odashima's co-authors include Junichi Sadoshima, Chull Hong, Mitsuhiro Yokota, Soichiro Usui, Jing Liu, Hiromitsu Takagi, Dorothy E. Vatner, Stephen F. Vatner, Jill Thaisz and Ghassan Yehia and has published in prestigious journals such as Journal of Clinical Investigation, Circulation Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Mari Odashima

7 papers receiving 530 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mari Odashima Japan 6 324 201 169 59 41 7 538
Quanhai Chen United States 8 441 1.4× 194 1.0× 194 1.1× 140 2.4× 56 1.4× 8 664
Arkadeep Mitra India 10 251 0.8× 53 0.3× 183 1.1× 36 0.6× 34 0.8× 14 440
Hiroto Tsukano Japan 5 213 0.7× 168 0.8× 81 0.5× 131 2.2× 79 1.9× 6 457
Miao Yi China 10 190 0.6× 92 0.5× 41 0.2× 65 1.1× 38 0.9× 20 382
Jackie Bodnar United States 6 385 1.2× 123 0.6× 63 0.4× 32 0.5× 113 2.8× 7 545
Suguru Matsumoto Japan 11 308 1.0× 78 0.4× 68 0.4× 24 0.4× 99 2.4× 25 576
José Castellano Spain 10 180 0.6× 52 0.3× 90 0.5× 43 0.7× 60 1.5× 16 392
Weihua Wu China 11 333 1.0× 59 0.3× 66 0.4× 27 0.5× 28 0.7× 20 498
Jessica Díaz‐Elizondo Chile 9 231 0.7× 76 0.4× 41 0.2× 119 2.0× 26 0.6× 11 404
Aurobindo Chatterjee United States 9 357 1.1× 58 0.3× 69 0.4× 29 0.5× 130 3.2× 12 573

Countries citing papers authored by Mari Odashima

Since Specialization
Citations

This map shows the geographic impact of Mari Odashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Odashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Odashima more than expected).

Fields of papers citing papers by Mari Odashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mari Odashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Odashima. The network helps show where Mari Odashima may publish in the future.

Co-authorship network of co-authors of Mari Odashima

This figure shows the co-authorship network connecting the top 25 collaborators of Mari Odashima. A scholar is included among the top collaborators of Mari Odashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari Odashima. Mari Odashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Odashima, Mari, Soichiro Usui, Hiromitsu Takagi, et al.. (2007). Inhibition of Endogenous Mst1 Prevents Apoptosis and Cardiac Dysfunction Without Affecting Cardiac Hypertrophy After Myocardial Infarction. Circulation Research. 100(9). 1344–1352. 140 indexed citations
2.
Obata, Koji, Kohzo Nagata, Mitsunori Iwase, et al.. (2005). Overexpression of calmodulin induces cardiac hypertrophy by a calcineurin-dependent pathway. Biochemical and Biophysical Research Communications. 338(2). 1299–1305. 30 indexed citations
3.
Yamamoto, Shimako, Guiping Yang, Daniela Zablocki, et al.. (2003). Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. Journal of Clinical Investigation. 111(10). 1463–1474. 247 indexed citations
4.
Yamamoto, Shimako, Guiping Yang, Daniela Zablocki, et al.. (2003). Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. Journal of Clinical Investigation. 111(10). 1463–1474. 11 indexed citations
5.
Nagata, Kohzo, Koji Obata, Mari Odashima, et al.. (2002). AT 1 Receptor Blockade Reduces Cardiac Calcineurin Activity in Hypertensive Rats. Hypertension. 40(2). 168–174. 86 indexed citations
6.
Odashima, Mari, et al.. (2000). Inhibitory Properties of Japanese Quail Ovoinhibitor toward Lymphocyte Proliferations. Nihon Chikusan Gakkaiho. 71(1). 92–102. 1 indexed citations
7.
Otani, Hajime & Mari Odashima. (1997). Inhibition of proliferative responses of mouse spleen lymphocytes by lacto‐ and ovotransferrins. Food and Agricultural Immunology. 9(3). 193–201. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026